Blog

»  Posts By   June 2019 

OIG Issues Fraud Alert Related to Genetic Testing Scam

The Office of the Inspector General for Health and Human Services (OIG) recently issued a Fraud Alert to the public identifying a fraud scheme involving genetic testing. To reduce fraud and abuse in federal health care programs, including Medicare and Medicaid, the OIG actively investigates potentially fraudulent schemes that are used to obtain money from these programs and, when appropriate, issues alerts that identify practices that are potentially fraudulent. This Alert...

Frier Levitt Successfully Reverses Termination from PBM Network for a New York Pharmacy

A New York Pharmacy's network termination by a major PBM for a was recently rescinded as the result of emergent intervention from Frier Levitt. The PBM was alleging discrepancies in the pharmacy's credentialing document and, although the pharmacy's principal never made any intentional misrepresentations, the PBM nevertheless terminated the pharmacy and plan sponsors sent out notices to the pharmacy's patients. Frier Levitt assisted at all stages of the dispute. Frier...

Recent Aqua Pharmaceuticals Settlement Highlights Continued Focus on Speaker Programs and State Investigations

Last week, it was announced that the drugmaker formerly known as Aqua Pharmaceuticals, LLC (now Almirall, LLC) has agreed to pay $3.5 million to settle kickback claims stemming from a qui tam whistleblower suit brought by a former sales representative. Among the allegations were that Aqua improperly provided meals, tickets, gift cards and speaking engagements to dermatologists in exchange for prescribing Aqua's products. While providing prescribers items of value (such...